These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 21330322

  • 21. Utility of hemoglobin electrophoresis to distinguish between severe delayed hemolytic transfusion reaction versus hyperhemolysis syndrome.
    Lukin R, Law JY, Lokhandwala PM.
    Transfus Apher Sci; 2024 Jun; 63(3):103919. PubMed ID: 38582651
    [Abstract] [Full Text] [Related]

  • 22. The first reported case of anti-Dob causing an acute hemolytic transfusion reaction.
    Halverson G, Shanahan E, Santiago I, Mabile R, Thurrell T, Strupp AM, Wolf CF, Spruell P, Moulds MK.
    Vox Sang; 1994 Jun; 66(3):206-9. PubMed ID: 8036791
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia.
    Fabron A, Moreira G, Bordin JO.
    Sao Paulo Med J; 1999 Jan 07; 117(1):38-9. PubMed ID: 10413970
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV, Steane E, Cunningham G, Frenkel EP.
    Arch Intern Med; 1988 Nov 07; 148(11):2485-9. PubMed ID: 3142382
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R, Hendrickson JE.
    Transfus Clin Biol; 2019 May 07; 26(2):112-115. PubMed ID: 30857806
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
    Hindawi S, Badawi M, Elfayoumi R, Elgemmezi T, Al Hassani A, Raml M, Alamoudi S, Gholam K.
    Transfusion; 2020 Feb 07; 60 Suppl 1():S15-S21. PubMed ID: 32134130
    [Abstract] [Full Text] [Related]

  • 33. A Hemolytic Transfusion Reaction Caused by an Unexpected Leb Antibody.
    Delk AA, Gammon RR, Alvarez H, Benitez N, Bright F.
    Lab Med; 2021 May 04; 52(3):303-306. PubMed ID: 33399868
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM, Miller MJ, Chonat S, Stowell SR.
    Transfus Clin Biol; 2019 May 04; 26(2):94-98. PubMed ID: 30837199
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Alloimmunization and hyperhemolysis in sickle cell disease.
    Pirenne F, Pondarré C.
    Hematology Am Soc Hematol Educ Program; 2023 Dec 08; 2023(1):653-659. PubMed ID: 38066873
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.